Literature DB >> 33793293

What Is the Optimal Model to Estimate the Benefits of Chemotherapy in Patients With Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer?

Kenju Ando1, Akihiko Shimomura1, Kenichi Yoshimura1, Yukino Kawamura1, Chikako Shimizu1.   

Abstract

Entities:  

Year:  2021        PMID: 33793293     DOI: 10.1200/JCO.21.00178

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Reply to K. Ando et al.

Authors:  Joseph A Sparano; Michael R Crager; Gong Tang; Robert J Gray; Salomon M Stemmer; Steven Shak
Journal:  J Clin Oncol       Date:  2021-04-01       Impact factor: 50.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.